BiomeBank Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10M

  • Investors
  • 6

BiomeBank General Information

Description

Operator of a biotechnology company intended to facilitate microbial therapies. The company uses a unique combination of machine learning and microbiology to identify bacterial strains that influence disease and is developing a pipeline of microbiome therapies, enabling doctors to treat and prevent disease by restoring gut microbial ecology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 3, 21-24 North Terrace
  • Adelaide, South Australia 5000
  • Australia
+61 (08)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Level 3, 21-24 North Terrace
  • Adelaide, South Australia 5000
  • Australia
+61 (08)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiomeBank Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 16-Apr-2026 $10M Completed Generating Revenue
4. Later Stage VC 02-Nov-2022 Completed Generating Revenue
3. Later Stage VC 30-Jun-2021 Completed Clinical Trials - General
2. Grant 24-Jun-2021 $100K $500K Completed Startup
1. Seed Round 04-Dec-2018 $500K $500K Completed Startup
To view BiomeBank’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BiomeBank Patents

BiomeBank Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025904346-A0 Lyophilized compositions Pending 18-Sep-2025
AU-2025900416-A0 Novel co-cultured microbial consortia and methods Inactive 14-Feb-2025
AU-2024902944-A0 Microbiota compositions and methods for treating disorders Inactive 16-Sep-2024
WO-2026036185-A1 Novel co-cultured microbial consortia and methods Pending 16-Aug-2024
AU-2025236357-A1 Microbiota compositions and methods for treating disorders Pending 15-Mar-2024 A61K35/74
To view BiomeBank’s complete patent history, request access »

BiomeBank Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiomeBank Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blackmores Corporation Minority
Ellerston Capital Asset Manager Minority
South Australian Venture Capital Fund Venture Capital Minority
Innovative Manufacturing Cooperative Research Centre Government
Artesian Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

BiomeBank FAQs

  • When was BiomeBank founded?

    BiomeBank was founded in 2016.

  • Where is BiomeBank headquartered?

    BiomeBank is headquartered in Adelaide, Australia.

  • What is the size of BiomeBank?

    BiomeBank has 37 total employees.

  • What industry is BiomeBank in?

    BiomeBank’s primary industry is Pharmaceuticals.

  • Is BiomeBank a private or public company?

    BiomeBank is a Private company.

  • What is the current valuation of BiomeBank?

    The current valuation of BiomeBank is .

  • What is BiomeBank’s current revenue?

    The current revenue for BiomeBank is .

  • How much funding has BiomeBank raised over time?

    BiomeBank has raised $42.7M.

  • Who are BiomeBank’s investors?

    Blackmores, Ellerston Capital, South Australian Venture Capital Fund, Innovative Manufacturing Cooperative Research Centre, and Artesian are 5 of 6 investors who have invested in BiomeBank.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process